These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11971944)

  • 21. HDL capacity to inhibit LDL oxidation in well-trained triathletes.
    Brites F; Zago V; Verona J; Muzzio ML; Wikinski R; Schreier L
    Life Sci; 2006 May; 78(26):3074-81. PubMed ID: 16488445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
    Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
    J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrasting in vivo effects of murine and human apolipoprotein A-II. Role of monomer versus dimer.
    Gong EL; Stoltfus LJ; Brion CM; Murugesh D; Rubin EM
    J Biol Chem; 1996 Mar; 271(11):5984-7. PubMed ID: 8626380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
    Moradi H; Pahl MV; Elahimehr R; Vaziri ND
    Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.
    Boemi M; Leviev I; Sirolla C; Pieri C; Marra M; James RW
    Atherosclerosis; 2001 Mar; 155(1):229-35. PubMed ID: 11223446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
    Stafforini DM; McIntyre TM; Carter ME; Prescott SM
    J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic lipase affects both HDL and ApoB-containing lipoprotein levels in the mouse.
    Braschi S; Couture N; Gambarotta A; Gauthier BR; Coffill CR; Sparks DL; Maeda N; Schultz JR
    Biochim Biophys Acta; 1998 Jun; 1392(2-3):276-90. PubMed ID: 9630674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
    Van Lenten BJ; Hama SY; de Beer FC; Stafforini DM; McIntyre TM; Prescott SM; La Du BN; Fogelman AM; Navab M
    J Clin Invest; 1995 Dec; 96(6):2758-67. PubMed ID: 8675645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
    Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.
    Noto H; Hara M; Karasawa K; Iso-O N; Satoh H; Togo M; Hashimoto Y; Yamada Y; Kosaka T; Kawamura M; Kimura S; Tsukamoto K
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):829-35. PubMed ID: 12649088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response.
    Cabana VG; Reardon CA; Feng N; Neath S; Lukens J; Getz GS
    J Lipid Res; 2003 Apr; 44(4):780-92. PubMed ID: 12562837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.
    Hedrick CC; Castellani LW; Warden CH; Puppione DL; Lusis AJ
    J Biol Chem; 1993 Sep; 268(27):20676-82. PubMed ID: 8376417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic disorders of serum lipoproteins in endotoxin-poisoned mice: the role of high density lipoprotein (HDL) and triglyceride-rich lipoproteins.
    Sakaguchi S
    Microbiol Immunol; 1982; 26(11):1017-34. PubMed ID: 6220193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
    Kontush A; de Faria EC; Chantepie S; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):526-33. PubMed ID: 14739123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL.
    Elsøe S; Ahnström J; Christoffersen C; Hoofnagle AN; Plomgaard P; Heinecke JW; Binder CJ; Björkbacka H; Dahlbäck B; Nielsen LB
    Atherosclerosis; 2012 Mar; 221(1):91-7. PubMed ID: 22204862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modified lipoproteins in periodontitis: a link to cardiovascular disease?
    Ljunggren S; Bengtsson T; Karlsson H; Starkhammar Johansson C; Palm E; Nayeri F; Ghafouri B; Davies J; Svensäter G; Lönn J
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30842338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
    Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL
    Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
    Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M
    J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human apolipoprotein A-II associates with triglyceride-rich lipoproteins in plasma and impairs their catabolism.
    Dugué-Pujol S; Rousset X; Pastier D; Quang NT; Pautre V; Chambaz J; Chabert M; Kalopissis AD
    J Lipid Res; 2006 Dec; 47(12):2631-9. PubMed ID: 16990646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
    Brunzell JD; Albers JJ; Chait A; Grundy SM; Groszek E; McDonald GB
    J Lipid Res; 1983 Feb; 24(2):147-55. PubMed ID: 6403642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.